Some of the genes associated with these 16 sites included PLEKHA7, AP1M2, ATP9A, and ARVCF known to be downregulated in breast and prostate cancer (data not shown), as well as other cancers [30–35]. This evidence concerns the gene ATP9A and prostate cancer.